Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies (Terumo BCT) is a global medical technology company focused on blood and cell-based therapies. As a division of Terumo Corporation, founded in 1921, it is headquartered in Lakewood, Colorado, and operates in over 150 countries. The company serves blood and plasma collection centers, hospitals, and cell therapy developers, aiming to enhance patient outcomes through innovative solutions. Terumo BCT offers a comprehensive range of products and services, including automated blood component and plasma collection systems, therapeutic apheresis devices, and advanced manufacturing platforms for cell and gene therapies. Their digital solutions, such as the Kinari Device Management Platform, integrate device management and customer support to improve operational efficiency. The company also provides clinical support services to strengthen customer relationships and enhance healthcare delivery. With a commitment to ensuring a safe and sustainable blood supply, Terumo BCT works to advance standards of care and improve access to blood and cell-based treatments. Their mission is to support lifesaving transfusions and enable the development of personalized therapies, ultimately aiming to improve healthcare on a global scale.

• Employees 6500
• Founded 1964
• Annual Revenue $1344000000
• Total Funding $17400000